Evidence map›Paper›PMID 40874065›Full record

ReviewFASEB bioAdvances2025

Beyond the Gut: Unveiling Methane's Role in Broader Physiological Systems.

Matthew Kerr, Madeleine Ball, Nabeetha Nagalingam, Rui Pinto-Lopes, Max Allsworth, Billy Boyle

Abstract readReview
In one paragraph

Review in FASEB bioAdvances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew KerrOwlstone Medical Ltd. Cambridge UK.ORCID https://orcid.org/0009-0007-9791-1845
Madeleine BallOwlstone Medical Ltd. Cambridge UK.
Nabeetha NagalingamOwlstone Medical Ltd. Cambridge UK.
Rui Pinto-LopesOwlstone Medical Ltd. Cambridge UK.
Max AllsworthOwlstone Medical Ltd. Cambridge UK.
Billy BoyleOwlstone Medical Ltd. Cambridge UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in the endogenous role of methane has grown rapidly over the past decade, driven both by its relevance for disease detection (including intestinal methanogen overgrowth) as well as discoveries that raise the possibility of endogenous sources of methane and suggestive evidence of methane effects relevant to physiology. This review explores both established and emerging origins of breath methane, its physiological relevance, and the evolving landscape of detection methods. We aim to summarize current understanding and provide a platform to outline key directions for future research. Evidence supports the existence of non-microbial, endogenous methane production pathways and potential biological effects beyond the gut. However, the concentrations generated via these pathways and the levels required to elicit physiological responses remain under investigation. Recent technological advances have enabled more accessible and longitudinal breath methane monitoring, opening new avenues for research and clinical application.

Indexed as

biological markerbreath testmethanephysiologytranslational research

Identifiers

PMID40874065
PMCPMC12378665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.